14 February 2012

Pneumomediastinum Ppts and 50 Published articles



Pneumomediastinum is air in the mediastinum. The mediastinum is the space in the middle of the chest, between the lungs. Pneumomediastinum is uncommon. The condition can be caused by injury or disease. Most often, it occurs when air leaks from any part of the lung or airways into the mediastinum.

Pneumomediastinum
by Tyler Bagley
Pneumomediastinum.ppt

Esophageal  Rupture
by Erin  M. Will
Presentations/Esophageal%20Rupture.ppt

Normal Newborn  Chest
NEWBORN%20CHEST%20REVIEW.ppt

Pneumomediastinum
by Gregory  R. Ball, Ph.D.
Pneumomediastinum.ppt

Medical Aspects of Blast Injuries
by Matthew D. Sztajnkrycer, MD, PhD
17011-18001/17971.ppt

Respiratory  Distress Syndrome (RDS)
Also known  as Hyaline Membrane Disease (HMD)
Neonatal%20Diseases.ppt

Chest X-Rays  Every Resident Should Know
by Arcot  J. Chandrasekhar, M.D., F.A.C.P.
pulmonar/cxr/ACP/ACP1.ppt

High  Frequency Ventilation
by Mark Willing,  RRT-NPS
L1HFV.ppt

Infant Lung Disease and Associated Complications
by Mary P. Martinasek, BS, RRT
Ch%2010%20ILD%20and%20Associated%20Complications.ppt

Diving Emergencies
Medical%20Emergencies/ENVIRONMENTAL/Diving%20Emergencies.ppt

Pediatric GU  Dysfunction
GU%20Dysfunction.ppt

Pertussis
by Mini Wallace,  DO
documents/nc_archive_68.ppt

Latest 50 published articles

Read more...

13 February 2012

Vasopressor Ppt and Latest 50 Published articles



Vasopressor: causing an increase in blood pressure by constricting the arteries;  a substance that has such an effect.

Cardiovascular  management of septic  shock
Cardiovascular%20management%20of%20septic%20shock.ppt

Vasoactive  Agents in Emergency Care
by Susan  P. Torrey, M.D., FACEP
http://vietnamem.org/ubr_uploads/MD_2012/EN_Vasopressors.ppt

Updates in Haemodynamics Support
by Dr.  OY Tam, Dr. LL Chang
ICU-Surgical%20Inter-departmental%20Grand%20Round%20v2.ppt

Inotropes & Vasopressors
by Dr  Cathy Armstrong
Inotropesvasopressors.ppt

Pressors
by Scott  Forman, D.O.
pcommed.com/Pressors.ppt

Vasoactive  drugs in the intensive  care unit
by Holmes, Cheryl L
vasoactive drugs.ppt

Steroids  in Vasopressor-Dependent Sepsis
by Melissa  Hynes, MD
SteroidSepsis.ppt

Overview  and Use of Pressors
Emphasis on Cardiogenic, Neurogenic, and Septic Shock
by Alexander  R. Raines, M.D
Overview%20and%20Use%20of%20Pressors%20%20%20%20Raines.ppt

Arginine  Vasopressin in Advanced  Vasodilatory Shock
http://www.anesthesia21.com/board/data/DeptNews/AVP.ppt

Management of Septic Shock
http://sparmy.com/Quake%20stuff/hypertension/SEPSISrevised.PPT

Latest 50 Publications

Read more...

11 February 2012

Current Clinical Trials on Vitiligo / Switra in Ayurveda / Venpadai in Siddha




Current Clinical Trials on Vitiligo (Switra in Ayurveda, Venpadai in Siddha)

  1. HI-Light Pilot Trial for Vitiligo: Hand Held NB-UVB for Early or Focal Vitiligo at Home
  2. Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo
  3. Vitiligo Skin Transplantation
  4. Ginkgo Biloba for the Treatment of Vitiligo Vulgaris in Adolescents
  5. Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis)
  6. Effect of Fluticasone Proprionate 0.05% on Narrow Band UV-B in Active Vitiligo
  7. Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo (NSV)
  8. Clinical Trial of Simvastatin to Treat Generalized Vitiligo
  9. Botulinum Toxin Treatment for Localized Vitiligo
  10. Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo
  11. Punchgrafting Techniques for Vitiligo
  12. Efficacy and Safety of ACH24 in the Treatment of Vitiligo
  13. Treatment of Vitiligo With Low-energy Visible Light Laser
  14. Narrowband UVB Treatment in Patients With Vitiligo
  15. Topical Bimatoprost Solution 0.03%in Stable Vitiligo
  16. Study of Applications of Autologous Epidermal Cells in Liquid Phase in the Treatment of Vitiligo
  17. Epidermal Cell Transplantation in Vitiligo Skin With and Without Narrow-band Ultraviolet B (UVB) Treatment
  18. Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult Vitiligo
  19. Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo
  20. Questionnaire and Laboratory Data on Vitiligo Vulgaris
  21. Emervel Deep Lidocaine vs. Juvederm® Ultra Plus in Treatment of Moderate to Severe Facial Wrinkles and Folds
  22. Safety Study of Cosmetic Tissue Augmentation in People of Color
  23. Trial for the Evaluation of the Effect of Systemic Low-dose Interleukin-2 (IL-2) on the Immunogenicity of a Vaccine Comprising Synthetic Melanoma Peptides Administered With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With High Risk Melanoma
  24. Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo
  25. A Post-Market Study to Evaluate Adverse Event Incidence Rates in Patients With Skin of Color Undergoing Correction of Nasolabial Folds With Hylaform, Hylaform Plus and Captique.
  26. Assessment of Atrophogenic Potential of Triple Combination Cream for Treatment of Melasma
  27. Post Market Safety Study and Effectiveness With Evolence in Subjects With Skin Color Types IV-VI

Read more...
All links posted here are collected from various websites. No video or powerpoint files are uploaded on this blog. If you are the original author and do not wish to display your content on this blog please Email me anandkumarreddy at gmail dot com I will remove it. The contents of this blog are meant for educational purpose and not for commercial use. If you use any content give due credit to the original author.

This site uses cookies from Google to deliver its services, to personalise ads and to analyse traffic. Information about your use of this site is shared with Google. By using this site, you agree to its use of cookies.

  © Blogger templates Newspaper III by Ourblogtemplates.com 2008

Back to TOP